Research Article
Plasma Methylated RNF180 for Noninvasive Diagnosis of Gastric Cancer
Table 2
Sensitivity, specificity, PPV, and NPV of mRNF180 and serum tumor markers.
| | Sensitivity (95% CI) | Specificity (95% CI) | PPV (95% CI) | NPV (95% CI) |
| | mRNF180 | 71.67 (58.36-82.18) | 59.38 (48.85-69.14) | 52.44 (41.18-63.47) | 77.03 (65.52-85.68) | | CEA | 28.33 (17.82-41.64) | 95.83 (89.07-98.66) | 80.95 (57.42-93.71) | 68.15 (59.50-75.75) | | CA199 | 26.67 (16.45-39.89) | 92.71 (85.06-96.77) | 69.57 (46.99-85.94) | 66.92 (58.16-74.68) | | CA724 | 28.33 (17.82-41.64) | 88.54 (80.02-93.86) | 60.71 (40.73-77.87) | 66.41 (57.45-74.36) |
|
|
PPV: positive predictive value; NPV: negative predictive value.
|
